• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-17 产生的 γδT 细胞通过募集 Gr-1CD11b 髓源抑制细胞来改善肠道急性移植物抗宿主病。

IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1CD11b myeloid-derived suppressor cells.

机构信息

Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Hematology, Hangzhou First People's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Bone Marrow Transplant. 2021 Oct;56(10):2389-2399. doi: 10.1038/s41409-021-01299-6. Epub 2021 May 13.

DOI:10.1038/s41409-021-01299-6
PMID:33986497
Abstract

Acute graft-versus-host disease (aGVHD) is the most severe complication and the major cause of morbidity and mortality in patients who have received hematopoietic stem cell transplantation. Inflammation mediated by donor T cells and neighboring recipient cells is considered to be responsible for intestinal aGVHD. Interleukin (IL)-17A-producing γδT (γδT17) cells have been investigated as key players in cancer, immunity, and inflammatory responses because of their phenotypic plasticity, memory-like activity, and unique migratory features. However, the precise roles and underlying mechanisms of γδT17 cells in aGVHD immunopathogenesis remain elusive. Here, we found that γδT17 cells constituted the major resident γδT population in the intestinal lamina propria of aGVHD mice. Adoptive infusion of induced γδT17 cells markedly attenuated murine aGVHD and increased infiltration of Gr-1CD11b myeloid-derived suppressor cells (MDSCs) into the inflammatory intestine, and did not affect graft-versus-leukemia(GVL) effect. Further experiments indicated that γδT17 cells enhanced both migration ability and immunosuppressive activity of MDSCs. γδT17 cell-mediated protection in aGVHD was blunted by depletion of IL-17A or MDSCs. Our study clarifies an immune pathway where γδT17 cells play a protective role in murine aGVHD by recruiting MDSCs to the inflammatory intestine.

摘要

急性移植物抗宿主病(aGVHD)是接受造血干细胞移植患者最严重的并发症和发病率及死亡率的主要原因。供体 T 细胞和邻近的受体细胞介导的炎症被认为是肠道 aGVHD 的原因。由于其表型可塑性、记忆样活性和独特的迁移特征,产生白细胞介素(IL)-17A 的 γδT(γδT17)细胞已被研究为癌症、免疫和炎症反应的关键参与者。然而,γδT17 细胞在 aGVHD 免疫发病机制中的确切作用和潜在机制仍不清楚。在这里,我们发现 γδT17 细胞构成了 aGVHD 小鼠肠道固有层中主要的常驻 γδT 群体。诱导的 γδT17 细胞的过继输注显著减轻了小鼠 aGVHD,并增加了 Gr-1CD11b 髓系来源抑制细胞(MDSC)浸润到炎症肠道,而不影响移植物抗白血病(GVL)效应。进一步的实验表明,γδT17 细胞增强了 MDSC 的迁移能力和免疫抑制活性。IL-17A 或 MDSC 的耗竭削弱了 γδT17 细胞在 aGVHD 中的保护作用。我们的研究阐明了一条免疫途径,其中 γδT17 细胞通过将 MDSC 募集到炎症肠道中来在小鼠 aGVHD 中发挥保护作用。

相似文献

1
IL-17-producing γδT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1CD11b myeloid-derived suppressor cells.IL-17 产生的 γδT 细胞通过募集 Gr-1CD11b 髓源抑制细胞来改善肠道急性移植物抗宿主病。
Bone Marrow Transplant. 2021 Oct;56(10):2389-2399. doi: 10.1038/s41409-021-01299-6. Epub 2021 May 13.
2
Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.脐带血来源的间充质基质细胞通过分泌 HLA-G 促进髓源性抑制细胞增殖,从而降低造血干细胞移植后急性移植物抗宿主病的发生。
Cytotherapy. 2020 Dec;22(12):718-733. doi: 10.1016/j.jcyt.2020.07.008. Epub 2020 Aug 15.
3
Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation.供体γδT细胞促进异基因造血干细胞移植中的移植物抗白血病效应并减轻急性移植物抗宿主病
Front Immunol. 2020 Oct 16;11:558143. doi: 10.3389/fimmu.2020.558143. eCollection 2020.
4
Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.异基因造血干细胞移植白血病患者循环中CD14(+) HLA-DR(-/低) 髓源性抑制细胞:预防和细胞治疗移植物抗宿主病的新型临床潜在策略
Cancer Med. 2016 Jul;5(7):1654-69. doi: 10.1002/cam4.688. Epub 2016 Apr 25.
5
Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.Galectin-9 表达增加是移植物抗宿主病(aGVHD)的预后生物标志物,在异基因造血干细胞移植后,通过 Galectin-9 诱导的髓系来源抑制细胞(MDSC)通路调节免疫反应。
Int Immunopharmacol. 2020 Nov;88:106929. doi: 10.1016/j.intimp.2020.106929. Epub 2020 Sep 1.
6
Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1CD11b myeloid suppressor cells.天然γδT17细胞通过募集Gr-1⁺CD11b⁺髓系抑制细胞在DSS诱导的结肠炎中发挥保护作用。
Oncoimmunology. 2017 Apr 5;6(5):e1313369. doi: 10.1080/2162402X.2017.1313369. eCollection 2017.
7
Graft-Versus-Host Disease Prevention by -Generated Myeloid-Derived Suppressor Cells Is Exclusively Mediated by the CD11b+CD11c+ MDSC Subpopulation.- 生成的髓源性抑制细胞通过抑制移植物抗宿主病的发生。 - 唯一由 CD11b+CD11c+MDSC 亚群介导。
Front Immunol. 2021 Oct 14;12:754316. doi: 10.3389/fimmu.2021.754316. eCollection 2021.
8
Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.髓源性抑制细胞疗法联合调节性T细胞可增强急性移植物抗宿主病中的免疫调节特性。
J Transl Med. 2020 Dec 14;18(1):483. doi: 10.1186/s12967-020-02657-6.
9
IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.供体 T 细胞中白细胞介素 22 缺乏可减轻小鼠急性移植物抗宿主病死亡率,同时不影响移植物抗白血病效应。
Leukemia. 2013 Jul;27(7):1527-37. doi: 10.1038/leu.2013.39. Epub 2013 Feb 12.
10
Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.体外生成的人脐血髓系来源的抑制细胞可减轻小鼠慢性移植物抗宿主病。
Biol Blood Marrow Transplant. 2018 Dec;24(12):2381-2396. doi: 10.1016/j.bbmt.2018.07.004. Epub 2018 Jul 11.

引用本文的文献

1
γδ T cells in hematological malignancies: mechanisms and therapeutic strategies.血液系统恶性肿瘤中的γδ T细胞:作用机制与治疗策略
Blood Sci. 2024 Dec 11;7(1):e00213. doi: 10.1097/BS9.0000000000000213. eCollection 2025 Jan.
2
Posttransplant complications: molecular mechanisms and therapeutic interventions.移植后并发症:分子机制与治疗干预
MedComm (2020). 2024 Sep 2;5(9):e669. doi: 10.1002/mco2.669. eCollection 2024 Sep.
3
JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.

本文引用的文献

1
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.细胞因子给药对接受肽疫苗的转移性黑色素瘤患者抗肿瘤反应产生的影响。
J Immunol. 1999 Aug 1;163(3):1690-5.
JAK1/2抑制剂芦可替尼通过JAK/STAT和ROS-MAPK/NF-κB信号通路促进急性移植物抗宿主病中多形核髓源性抑制细胞的扩增和抑制作用。
Clin Transl Immunology. 2023 Feb 25;12(2):e1441. doi: 10.1002/cti2.1441. eCollection 2023.